Negative Perceptions of Clinical Trials In India Persist – Clinical Trials Panel
This article was originally published in PharmAsia News
Executive Summary
SAN FRANCISCO - Companies looking to initiate clinical trials in India must tread lightly when navigating ethics committees, according to panelists at a recent conference on various aspects of entering clinical trials in Asia